Endogenous cell-associated IL-10 was assayed based on anti-inflammatory activity of 178 IL-10 to suppress LPS-induced TNF. M1and M2 Ms were pre-treated with 10 g/ml 179 9D7 neutralising anti-IL-10 antibody (Biolegend, San Diego, USA) or irrelevant, 180 isotype-matched control antibody for 30 minutes prior to stimulation with 100ng/ml PG-181 LPS and cultured for 18 hours at 37 o C, 5% CO2. In addition, M sensitivity to 182 exogenous IL-10 was assayed where M1 and M2s were pre-treated with exogenously 183 added IL-10 (0, 0.2, 2 and 20 ng/ml)(NIBSC, Potter's Bar, UK) for 30 minutes prior to 184 stimulation with 100ng/ml PG-LPS and cultured for 18 hours. Supernatants were 185 collected and assayed for TNF secretion by sandwich ELISA. M viability was 186 routinely checked by either MTT assay or trypan blue exclusion. A physiologically-187 relevant response was indicated, as no significant reductions in viability were observed 188 for any treatments used in this study (viability routinely >85%). 189
190

Cytokine measurement 191
TNF and IL-10 were analysed by sandwich ELISA using commercially available 192 capture and detection antibodies (BD-Pharmingen, Oxford, UK). Protocols were 193 followed according to manufacturer's instructions and compared to standard curves 194 (range of 7 to 5,000 pg/ml), using international standards available from NIBSC.
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